Package 50090-6247-0

{"route": ["ORAL"], "spl_id": "a3c4a0eb-71e8-4b35-9706-240874b78ee0", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "unii": ["4L5MP1Y7W7", "G70B4ETF4S", "FWF6Q91TZO"], "rxcui": ["1999667", "1999673"], "spl_set_id": ["0476d7eb-1024-4821-bbe7-abaacfda32a2"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (50090-6247-0)", "package_ndc": "50090-6247-0", "marketing_start_date": "20221128"}], "brand_name": "Biktarvy", "product_id": "50090-6247_a3c4a0eb-71e8-4b35-9706-240874b78ee0", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "50090-6247", "generic_name": "bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Biktarvy", "active_ingredients": [{"name": "BICTEGRAVIR SODIUM", "strength": "50 mg/1"}, {"name": "EMTRICITABINE", "strength": "200 mg/1"}, {"name": "TENOFOVIR ALAFENAMIDE FUMARATE", "strength": "25 mg/1"}], "application_number": "NDA210251", "marketing_category": "NDA", "marketing_start_date": "20180207", "listing_expiration_date": "20261231"}